Event Date/Time: Jan 31, 2012 End Date/Time: Feb 02, 2012
Early Registration Date: Sep 16, 2011
Report as Spam


BioBusiness 2012 - The leading high-level BioPharma strategy and bio-partnering conference
This leading bio-partnering conference is THE only place in London where VP to CEO level delegates from small biotech's through to top 10 pharma's and key financers behind innovation will gather to discuss high level strategy and build relationships. Forward thinking companies will come to make their next big deal.

We've listened to our delegates and BioBusiness 2012 returns to London in January with a revamped, strategically focused programme and speaker cohort based on your industry feedback!

Confirmed Speakers
Alan Moodie, Vice President, Business Development, GlaxoSmithKline Jackie Hunter, Founder and Chief Executive Officer, OI pharma partners
Alan Palkowitz, Vice President, Discovery Chemistry, Eli Lilly Jørgen Thorball, Managing Partner, XOventure Life Science Experts
Andrew Sandham, Chairman & CEO, Kymab Kimberly Brue, Senior Director, Alliance Management, Biogen Idec
Axel Polack, General Manager, TVM Capital* Mike Ward, Editor, Scrip Intelligence
Bernard Munos, Founder, InnoThink Center for Research in Biomedical Innovation Malcolm Weir, Chief Executive Officer, Heptares Therapeutics
Carole Nuechterlein, Head of Venture Investments, Roche Venture Funds Margaret Beer, Senior Director & Head, Licensing & External Research, Merck
Daphne Zohar, Founder, Managing Partner, PureTech Ventures* Martino Picardo, CEO, Stevenage Bioscience Catalyst
David Phillips, Partner, SR One Melanie Lee, CEO, Syntaxin
Denise Goode, Executive Transaction Director - Strategic Planning & Business Development, AstraZeneca Nicki Thompson, Director, Business Development, Alternative Discovery and Development, GlaxoSmithKline
Deborah Harland, Partner, SR One Onno van de Stolpe, Chief Executive Officer, Galapagos
Denise Pollard-Knight, CEO, Phase4 Ventures Peter Nolan, Executive Director, SVP Commercial Development, Oxford BioMedica
Francesco De Rubertis, Life Sciences Partner, Index Ventures Simon Haworth, MD, BSG Team Ventures
Gertjan Bartlema, Executive Director Marketing & Sales Excellence, Celgene Steven Holtzman, Executive Vice President, Corporate Development, Biogen Idec
Graeme Martin, President and CEO, Takeda Research Investment